A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.
Inclusion Criteria:
Exclusion Criteria:
Omaha, Nebraska 68124, United States
Philadelphia, Pennsylvania 19141, United States
Newport News, Virginia 23602, United States
Richmond, Virginia 23226, United States
CABA, 1430, Argentina
Rio de Janeiro, 21941-617, Brazil
Vancouver, British Columbia V5Z 1M9, Canada
Montreal, H2X 0A9, Canada
Wuhan, Hubei 430022, China
Hangzhou, Zhejiang 310003, China
Leipzig, 04103, Germany
Magdeburg, 39120, Germany
Jerusalem, 9112001, Israel
Ehime, 791-0295, Japan
Hokkaido, 006-8555, Japan
Birmingham, West Midlands B15 2GW, United Kingdom